GGrantIndex
← Search

INHALED VS. SUBCUTANEOUS HUMAN INSULIN THERAPY IN TYPE 2 DIABETES

$0M01FY2000RRNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Abstract

To determine, in subjects with type 2 diabetes mellitus: Whether glycemic control can be achieved at least as effectively w an insulin regimen involving pre-meal inhaled insulin plus a single bedtime Ultralente injection as with a conventional subcutaneous insulin regimen involving 2 mixed Regular/NPH insulin injections per day.

View original record on NIH RePORTER →